Spinoff Tracker

Every US corporate spin-off, sourced from the filing that proves it.

Corteva, Inc. CTVA → Vylor Inc.

Distributionpending
ParentCorteva, Inc. CTVA
SpincoVylor Inc.
StatusAnnounced
StructureSpin-off A filing states a pro-rata distribution: holders receive shares automatically.
FocusFocus-increasing Parent and spinco operate in different industries — the class the research associates with stronger post-separation returns.
Rationot declared
Checked against EDGAR2026-08-21

Data trap

Corteva's seed business is the larger half of the company by revenue, and it is the half leaving. Every current CTVA revenue, margin and multiple describes a combined company that will not exist after the separation; there is no restated filing for the continuing crop-protection business yet.

Still live.

Catalyst clock

  1. 2025-10-01Separation announced
  2. 2026-06-29Form 10 filed
  3. 2026-08-14Form 10 last amended
  4. Form 10 effective
  5. Record date
  6. When-issued trading opens
  7. Distribution
  8. First standalone earnings
  9. Index inclusion announced

Filings

Every fact on this page comes from one of these.

Notes

Corteva is separating its seed business as Vylor, with crop protection remaining as 'New Corteva'. The information statement records the plan as announced on 2025-10-01 and notes that on 2026-07-30 Corteva said it expected to complete the separation on or about 2026-10-01 — that expectation is not a declared date, so distribution stays null until a filing sets one. Ratio is null for the same reason: Amendment No. 1 still shows a placeholder. An internal EIDP distribution step precedes the spin, and EIDP preferred stock stays with New Corteva. focus_class is resolved from the Form 10 itself rather than waiting for completion: Vylor is defined as the seed-genetics business (licensing, gene editing, hybrid wheat, biofuels) and New Corteva retains crop protection/biologicals — a 'fit-for-purpose' split of what SIC records as one identical agricultural-production code. Vylor is being spun off levered: pro forma capitalization shows roughly $5.6 billion of borrowings against $12.3 billion of equity, including $1.28 billion in notes issued to settle an exchange offer for legacy EIDP debt. Distribution date, ratio and share count remain null pending the deal's completion, as before.